Vitamin B12
Code:12007|CPT:82607|LOINC:2132-9
| Includes | Vitamin B12 |
|---|
Analysis details
Methodology
- Electrochemiluminescence immunoassay (ECLIA)
- Chemiluminescent immunoassay (CLIA)
Expected Turnaround Time
1 day
Special Instructions
- Do not eat for 2–3 hours before the blood draw; water is allowed.
- Avoid physical exertion and emotional stress for 30 minutes prior to collection.
- Do not smoke during the 30 minutes before collection.
- If using high-dose biotin supplements, stop for at least 72 hours before collection; document and review biotin use prior to testing.
How to use
The Vitamin B12 test (serum cobalamin, cyanocobalamin) is used to assess macrocytic or megaloblastic anemia and to investigate neurologic or neuropsychiatric features attributable to cobalamin deficiency. It supports evaluation of malnutrition and malabsorption states such as celiac disease and Crohn disease, assessment in alcoholism, review of prenatal care/nutritional status, and monitoring of treatment for confirmed vitamin B12 deficiency. Markedly increased serum B12 may accompany liver disease or myeloid leukemia. Interpretation should be integrated with clinical findings and related studies, including folate, homocysteine, and complete blood count indices.
Limitations
Serum measurement of vitamin B12 is a standard approach to evaluate cobalamin status. Dietary sources are predominantly animal-derived foods—meat (notably liver and kidney), fish, eggs, and dairy—with additional intake from certain fortified grain products. Cobalamin is required for nucleic acid synthesis, erythropoiesis, and maintenance of neurologic integrity; deficiency produces megaloblastic anemia and may involve the posterior columns and corticospinal tracts, presenting with distal paresthesias and sensory loss. Causes of deficiency include inadequate intake (eg, prolonged strict vegetarian patterns or starvation), impaired absorption (eg, pernicious anemia from intrinsic factor deficiency, celiac disease, Crohn disease, achlorhydria, or postsurgical reduction of absorptive surface), decreased utilization in liver or kidney disease and with alcohol misuse, and increased requirements (eg, hemolytic anemia, hyperthyroidism, alpha-thalassemia).
| Unit | pg/mL | ||||
|---|---|---|---|---|---|
| Reference interval |
| ||||
| Indications | Macrocytosis or an increased mean corpuscular volume on CBC., Cognitive or behavioral changes such as confusion, depression, paranoia, or other neuropsychiatric symptoms, especially in older adults., Clinical suspicion of cobalamin deficiency with systemic or gastrointestinal findings (eg, fatigue, glossitis, hepatomegaly)., Peripheral neuropathy with paresthesias, numbness, or sensory loss., Workup of malnutrition or possible malabsorption, including celiac disease or Crohn disease., Maternal testing when a breastfed infant is found to be vitamin B12 deficient., Follow-up to track response to therapy in documented vitamin B12 deficiency. |
Possible Causes of Abnormal Results
Increased levels
- biotin supplementation (high-dose)
- folic acid therapy in concurrent folate and vitamin B12 deficiency
- liver disease
- myeloid leukemia
- vitamin B12 therapy
Decreased levels
- alcohol abuse
- antibiotics
- anticonvulsants
- colchicine
- oral contraceptives
- vegetarian or vegan diet
Specimen Requirements
| Specimen | Serum |
|---|---|
| Container | Gold/Tiger Top (SST, Gel Separator) |
| Volume | 1 mL (min 0.7 mL) |
| Storage Instructions | Room temperature, Refrigerated, Frozen |